Skip to main content

Cannula Market | Increasing Demand of Cannula in Home Healthcare & Emerging Markets To Boost The Market

The report “Cannulas Market by Product (Nasal, Arterial, Arthroscopy, Ophthalmic, Cardioplegia, Suction, Femoral, Injector, Infusion, Venous, Microcannula), Material (Plastic, Metal) & End Users (Hospitals, Ambulatory Surgical Centers) – Global Forecast to 2020”, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue.
Browse 86 market data tables and 52 figures spread through 156 pages and in-depth TOC on “Cannulas Market by Product (Nasal, Arterial, Arthroscopy, Ophthalmic, Cardioplegia, Suction, Femoral, Injector, Infusion, Venous, Microcannula), Material (Plastic, Metal) & End Users (Hospitals, Ambulatory Surgical Centers) – Global Forecast to 2020″.

https://www.marketsandmarkets.com/Market-Reports/cannula-market-267615076.html
Early buyers will receive 10% customization on reports.

The cannulas market is poised to reach $135.5 million by 2020 from $97.6 million in 2014 at a CAGR of 5.6% from 2015 to 2020.The increasing number of surgeries, advancement in the healthcare facilities, large pool of patients, and rising government funding are driving the cannulas market. In addition to this, increasing minimally invasive surgery (MIS) procedures is also one of the key drivers of cannulas market. On the other hand, uncertain regulatory framework in medical devices industry is the key factors limiting the growth of this market.
On the basis of products, the market is divided into cardiac cannulas, vascular cannulas, nasal cannulas, arthroscopy cannulas, dermatology cannulas and others (floating spinal cannulas, vitreoretinal cannulas, hysterosalpingography cannulas).


On the basis of end users, the market is divided into hospitals, ambulatory surgical centers, and others (blood banks and home healthcare facilities). The hospitals segment accounted for the largest and fastest growing market of the global cannulas market owing to  increasing demand for minimally invasive procedures in cardiovascular, cosmetic, and general surgeries. On the basis of material, the market is divided into plastic, silicone, and metal. The plastic material is estimated to be the largest segment during the forecast period.

Geographically, the cannulas market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America accounted for the largest share of the cannulas market, followed by Europe and Asia Pacific. Both these markets are estimated to register single-digit growth rates over the next five years. However, Asia-Pacific is expected to register the highest growth rate during the forecast period owing to the increasing government support, growth in the purchasing power in the middle class population, and increasing awareness about MIS techniques in different surgical procedures. Growth of the cannulas market in the Asia-Pacific region will revolve around China, India, Australia, and Japan.

The key players in this market includes Medtronic plc (U.S.), Edward Lifesciences Corp. (U.S.), Terumo Corporation (Japan), Sorin Group (Italy), and Maquet Holding B.V. & Co. KG (Germany).



Article Credit: Healthcare DC
Labels:

Comments

Post a Comment

Popular posts from this blog

NGS-Based RNA-Sequencing Industry is Growing at a CAGR of 20%

NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market. NGS-based RNA-sequencing Market: Impact Analysis 1. NGS-Based RNA-Sequencing: Market Overview 2. Geographical Snapshot of the NGS-Based RNA-Sequencing Market 3. Rapid Growth in Precision Medicine 4. Growing Number of Research Activities Involving RNA-Seq 5. Increasing Applications of RNA-Seq in Research ( Cancer and Agricultural) The NGS-based RNA-sequencing market size is estimated to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a CAGR of 20.0%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global NGS-based RNA-sequencing market? 2. What are the drivers, restraints, opportunities, and challenges in the NGS-based RNA-sequencing Industry? 3. What are th...
Post a Comment
Read more

Digital Diabetes Management Market to Reach $19.98 billion by 2024 | Market and Regional Growth Analysis

  Digital diabetes management solutions are smartphone-connected diabetes management devices and software platforms used by patients suffering from Type 1, Type 2, and gestational diabetes. Medical professionals also use these solutions to manage diabetes. Various digital diabetes management devices such as smart glucose meters, continuous glucose monitoring systems, smart insulin pens, and smart insulin pumps/closed-loop systems and smart insulin patches are used for glucose monitoring and insulin delivery. Diabetes management applications, data management software & platforms, and services are used by patients and healthcare providers for remote monitoring, data analysis, and disease management. The Digital Diabetes Management Market is experiencing significant growth due to rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly...
Post a Comment
Read more

Epigenetics Market | Major Market Dynamics Impacting The Global Industry

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strateg...
Post a Comment
Read more